Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Swain

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of indole substitutionL C Cooper, G G Chicchi, K Dinnell, et al.
Journal of Medicinal Chemistry|November 7, 1998
4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activityG I Stevenson, I Huscroft, A M MacLeod, et al.
European Journal of Pharmacology|May 20, 1997
In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonistsN M Rupniak, F D Tattersall, A R Williams, et al.
Journal of Medicinal Chemistry|July 19, 1996
N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonistsT Ladduwahetty, R Baker, M A Cascieri, et al.
Science (New York, N.Y.)|September 11, 1998
Distinct mechanism for antidepressant activity by blockade of central substance P receptorsM S Kramer, N Cutler, J Feighner, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of indole substitutionL C Cooper, G G Chicchi, K Dinnell, et al.
Journal of Medicinal Chemistry|November 7, 1998
4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activityG I Stevenson, I Huscroft, A M MacLeod, et al.
European Journal of Pharmacology|May 20, 1997
In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonistsN M Rupniak, F D Tattersall, A R Williams, et al.
Journal of Medicinal Chemistry|July 19, 1996
N-heteroaryl-2-phenyl-3-(benzyloxy)piperidines: a novel class of potent orally active human NK1 antagonistsT Ladduwahetty, R Baker, M A Cascieri, et al.
Science (New York, N.Y.)|September 11, 1998
Distinct mechanism for antidepressant activity by blockade of central substance P receptorsM S Kramer, N Cutler, J Feighner, et al.
Pageof 3